Ademetionine PCD Pharma Franchise Company

Cafoli Lifecare offers an Ademetionine range of 2 tablet formulations manufactured in WHO-GMP certified facilities. Distributors targeting the growing liver-care and hepatology segment can secure district-wise monopoly franchise rights for our Ademetionine tablets with full promotional backing.

What is Ademetionine?

Ademetionine (S-adenosyl-L-methionine, or SAMe) is a naturally occurring molecule that acts as a methyl-group donor and precursor in glutathione synthesis. In hepatology it is used to restore hepatic function in intrahepatic cholestasis and cholestasis of pregnancy, and it has also been studied in liver disease and depressive symptoms. Reference: PubChem - S-Adenosylmethionine.

Ademetionine Tablet Formulations

Therapeutic Applications

Ademetionine is prescribed for intrahepatic cholestasis, cholestasis of pregnancy and supportive management of chronic liver disorders. Prescribers include hepatologists, gastroenterologists, physicians and obstetricians managing cholestatic conditions.

Why Ademetionine is a High-Potential Molecule for Distributors

Liver disorders are rising in India on the back of fatty liver disease, alcohol use and hepatitis, and ademetionine is a premium, higher-value hepatoprotective that few PCD companies stock. Because therapy in cholestasis runs for weeks and the per-pack value is high, a single hepatology or gastro prescriber can generate strong recurring revenue for the distributor.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs to help you build the territory.

References

1. PubChem: S-Adenosylmethionine
2. PubMed: ademetionine in intrahepatic cholestasis
3. MedlinePlus: SAMe (S-adenosylmethionine)